Alliance Healthcare Group Limited (SGX:MIJ)
0.1340
+0.0050 (3.88%)
At close: Feb 27, 2026
Alliance Healthcare Group Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 81.51 | 77.11 | 67.98 | 58 | 54.76 | 46.42 |
Other Revenue | 0.01 | 0.01 | 0.01 | 0.01 | - | - |
| 81.51 | 77.12 | 67.99 | 58.01 | 54.76 | 46.42 | |
Revenue Growth (YoY) | 12.82% | 13.43% | 17.20% | 5.95% | 17.97% | 8.49% |
Cost of Revenue | 66.37 | 63.86 | 58.2 | 49.59 | 45.05 | 39.65 |
Gross Profit | 15.14 | 13.26 | 9.79 | 8.43 | 9.7 | 6.77 |
Selling, General & Admin | 0.66 | 0.66 | 0.49 | 0.78 | 0.69 | 0.59 |
Other Operating Expenses | 6.16 | 5.76 | 4.45 | 2.3 | 1.4 | 1.79 |
Operating Expenses | 11.96 | 11.35 | 8.95 | 5.9 | 4.91 | 5.24 |
Operating Income | 3.18 | 1.91 | 0.84 | 2.53 | 4.79 | 1.53 |
Interest Expense | -0.72 | -0.87 | -0.87 | -0.42 | -0.23 | -0.26 |
Interest & Investment Income | 0 | 0.01 | 0.08 | 0.01 | - | 0.01 |
Earnings From Equity Investments | 0.14 | 0 | -0.14 | -0.08 | -0.07 | - |
Currency Exchange Gain (Loss) | 0.11 | 0.11 | 0.07 | 0.07 | 0.1 | 0.07 |
Other Non Operating Income (Expenses) | -0.02 | - | 0.05 | 0.05 | 0.35 | -0.04 |
EBT Excluding Unusual Items | 2.7 | 1.16 | 0.03 | 2.16 | 4.95 | 1.3 |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | -0.01 | -0 | - | 0 |
Asset Writedown | - | - | - | - | -0 | -0 |
Legal Settlements | - | - | - | - | - | -0.32 |
Other Unusual Items | - | - | - | - | - | 1.37 |
Pretax Income | 2.71 | 1.17 | 0.02 | 2.16 | 4.95 | 2.35 |
Income Tax Expense | 0.38 | 0.08 | -0.33 | 0.15 | 0.64 | 0.34 |
Earnings From Continuing Operations | 2.33 | 1.1 | 0.35 | 2.01 | 4.31 | 2.01 |
Minority Interest in Earnings | 0.42 | 0.43 | 0.37 | 0.08 | -1.2 | -0.48 |
Net Income | 2.76 | 1.52 | 0.72 | 2.09 | 3.11 | 1.53 |
Net Income to Common | 2.76 | 1.52 | 0.72 | 2.09 | 3.11 | 1.53 |
Net Income Growth | - | 111.74% | -65.58% | -32.82% | 103.21% | -34.40% |
Shares Outstanding (Basic) | 206 | 206 | 206 | 206 | 208 | 208 |
Shares Outstanding (Diluted) | 206 | 206 | 206 | 206 | 208 | 208 |
Shares Change (YoY) | 0.20% | 0.15% | 0.02% | -0.88% | -0.12% | - |
EPS (Basic) | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
EPS (Diluted) | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
EPS Growth | - | 111.44% | -65.59% | -32.22% | 103.46% | -34.22% |
Free Cash Flow | 8.14 | 5.11 | 2.04 | 0.17 | 9.39 | 3.78 |
Free Cash Flow Per Share | 0.04 | 0.03 | 0.01 | 0.00 | 0.04 | 0.02 |
Dividend Per Share | 0.001 | 0.001 | - | 0.003 | 0.004 | 0.002 |
Dividend Growth | - | - | - | -33.33% | 95.65% | -32.35% |
Gross Margin | 18.58% | 17.20% | 14.40% | 14.52% | 17.72% | 14.58% |
Operating Margin | 3.91% | 2.48% | 1.24% | 4.36% | 8.76% | 3.30% |
Profit Margin | 3.38% | 1.98% | 1.06% | 3.60% | 5.68% | 3.30% |
Free Cash Flow Margin | 9.98% | 6.63% | 3.00% | 0.30% | 17.15% | 8.14% |
EBITDA | 4.93 | 3.55 | 2.19 | 3.17 | 5.44 | 2.55 |
EBITDA Margin | 6.05% | 4.60% | 3.22% | 5.47% | 9.93% | 5.49% |
D&A For EBITDA | 1.75 | 1.63 | 1.35 | 0.64 | 0.64 | 1.02 |
EBIT | 3.18 | 1.91 | 0.84 | 2.53 | 4.79 | 1.53 |
EBIT Margin | 3.91% | 2.48% | 1.24% | 4.36% | 8.76% | 3.30% |
Effective Tax Rate | 13.94% | 6.54% | - | 6.75% | 13.00% | 14.37% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.